Global $1+bn, pharmaceutical generics company based in India approached Freyr to streamline pharmacovigilance process for all marketed products in all geographies. While there was no existing process or technology to be implemented to maintain CCDS, the client was in urgent need to comply with HA requirements.
Learn how Freyr offered comprehensive Regulatory labeling services for harmonizing the PV data and made the client ready for HA audit.
Fill the form below to download the Case Study
